Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.

La Rosa S, Marando A, Gatti G, Rapa I, Volante M, Papotti M, Sessa F, Capella C.

Hum Pathol. 2013 Jul;44(7):1391-9. doi: 10.1016/j.humpath.2012.11.013. Epub 2013 Jan 31.

PMID:
23375646
2.

[Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].

Li F, Zhong Z, Li R, Huang H, Wang L, Zheng D, Zhang D.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):317-21. doi: 10.3779/j.issn.1009-3419.2010.04.09. Chinese.

3.

Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma.

Righi L, Rapa I, Votta A, Papotti M, Sapino A.

Virchows Arch. 2012 Apr;460(4):415-21. doi: 10.1007/s00428-012-1223-1. Epub 2012 Mar 16.

PMID:
22422124
4.

Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.

Shida T, Furuya M, Nikaido T, Kishimoto T, Koda K, Oda K, Nakatani Y, Miyazaki M, Ishikura H.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):450-8.

5.

Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification.

Cordes B, Williams MD, Tirado Y, Bell D, Rosenthal DI, Al-Dhahri SF, Hanna EY, El-Naggar AK.

Hum Pathol. 2009 Mar;40(3):283-92. doi: 10.1016/j.humpath.2008.07.019. Epub 2009 Jan 15.

6.

High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.

Findeis-Hosey JJ, Huang J, Li F, Yang Q, McMahon LA, Xu H.

Hum Pathol. 2011 Jun;42(6):867-72. doi: 10.1016/j.humpath.2010.09.019. Epub 2011 Feb 2.

PMID:
21292308
7.

Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors.

Taggart MW, Hanna EY, Gidley P, Weber RS, Bell D.

Ann Diagn Pathol. 2015 Jun;19(3):154-6. doi: 10.1016/j.anndiagpath.2015.03.009. Epub 2015 Apr 6.

PMID:
25892663
8.

Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.

Westerman BA, Breuer RH, Poutsma A, Chhatta A, Noorduyn LA, Koolen MG, Postmus PE, Blankenstein MA, Oudejans CB.

Int J Biol Markers. 2007 Apr-Jun;22(2):114-23.

PMID:
17549667
9.

hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.

Jiang SX, Kameya T, Asamura H, Umezawa A, Sato Y, Shinada J, Kawakubo Y, Igarashi T, Nagai K, Okayasu I.

Mod Pathol. 2004 Feb;17(2):222-9.

10.

Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.

Ball DW, Azzoli CG, Baylin SB, Chi D, Dou S, Donis-Keller H, Cumaraswamy A, Borges M, Nelkin BD.

Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5648-52.

11.

Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.

Westerman BA, Neijenhuis S, Poutsma A, Steenbergen RD, Breuer RH, Egging M, van Wijk IJ, Oudejans CB.

Clin Cancer Res. 2002 Apr;8(4):1082-6.

12.

Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung.

Miki M, Ball DW, Linnoila RI.

Lung Cancer. 2012 Jan;75(1):58-65. doi: 10.1016/j.lungcan.2011.05.019.

PMID:
21684625
13.

The expression of NeuroD and mASH1 in the gastroenteropancreatic neuroendocrine tumors.

Shida T, Furuya M, Kishimoto T, Nikaido T, Tanizawa T, Koda K, Oda K, Takano S, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Nakatani Y, Miyazaki M.

Mod Pathol. 2008 Nov;21(11):1363-70. doi: 10.1038/modpathol.2008.121. Epub 2008 Jun 27.

14.

Mouse lung neuroendocrine carcinomas: distinct morphologies, same transcription factors.

Linnoila RI, Naizhen X, Meuwissen R, Berns A, DeMayo FJ.

Exp Lung Res. 2005 Jan-Feb;31(1):37-55.

PMID:
15765918
15.

Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression.

Chen H, Thiagalingam A, Chopra H, Borges MW, Feder JN, Nelkin BD, Baylin SB, Ball DW.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5355-60.

16.

Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.

Hechtman JF, Beasley MB, Kinoshita Y, Ko HM, Hao K, Burstein DE.

Hum Pathol. 2013 Jul;44(7):1400-5. doi: 10.1016/j.humpath.2012.11.014. Epub 2013 Feb 14.

PMID:
23416030
17.

Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.

Gupta A, Wang Y, Browne C, Kim S, Case T, Paul M, Wills ML, Matusik RJ.

Prostate. 2008 Jan 1;68(1):50-60.

PMID:
18004726
18.

Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma.

Meyronet D, Massoma P, Thivolet F, Chalabreysse L, Rogemond V, Schlama A, Honnorat J, Thomasset N.

Am J Surg Pathol. 2008 Nov;32(11):1699-708. doi: 10.1097/PAS.0b013e31817dc37c.

PMID:
18769332
19.

Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.

Kazanjian A, Wallis D, Au N, Nigam R, Venken KJ, Cagle PT, Dickey BF, Bellen HJ, Gilks CB, Grimes HL.

Cancer Res. 2004 Oct 1;64(19):6874-82.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk